Optimal design of pharmacokinetic studies

Basic and Clinical Pharmacology and Toxicology

Volumn 106, Issue 3, 2010, Pages 250-255

  Aarons, Leon ^a   Ogungbenro, Kayode ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; EXPERIMENTAL DESIGN; EXPERIMENTAL MODEL; INFORMATION PROCESSING; MATHEMATICAL MODEL; PHARMACOKINETICS; POPULATION RESEARCH; PRIORITY JOURNAL; SAMPLE SIZE; THEORETICAL MODEL;

ANIMALS; BAYES THEOREM; DRUG INTERACTIONS; HUMANS; MODELS, STATISTICAL; PHARMACOKINETICS; PHARMACOLOGY, CLINICAL; RESEARCH DESIGN; SAMPLE SIZE;

EID: 77149147747     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00533.x     Document Type: Conference Paper

References (50)

1. Fisher RA. Statistical Methods for Research Workers, 13th edn. Oliver and Boyd, Edinburgh, 1958.
2. Fisher RA. The Design of Experiments, 8th edn. Hafner Publishing Company, New York, 1966.
3. Cochran WG, Cox GM. Experimental Designs, 2nd edn. Wiley, New York, 1957.
4. Davies OL. Design and Analysis of Industrial Experiments, 2nd edn. Hafner Publishing Company, New York, 1956.
5. Atkinson AC, Chaloner K, Herzberg AM, Juritz J. Optimum experimental designs for properties of a compartmental model. Biometrics 1993 49 : 325 337.
6. Haines LM. Optimal-design for nonlinear-regression models. Commun Stat Theory Methods 1993 22 : 1613 1627.
7. Atkinson AC, Haines LM, Ghosh S, Rao CR. Designs for Nonlinear and Generalized Linear Models. Handbook of Statistics 13. Elsevier Science, Amsterdam, 1996 437 476.
8. Box GEP, Lucas HL. Design of experiments in non-linear situations. Biometrika 1959 46 : 77 90.
9. Box MJ. Some experiences with a nonlinear experimental design criterion. Technometrics 1970 12 : 569 589.
10. Fedorov VV. Theory of Optimal Experiments. Academic Press, New York, 1972.
11. Fedorov VV, Hackl P. Model-Oriented Design of Experiments. Springer Verlag, New-York, 1997.
12. d'Argenio DZ, Schumitzky A. A program package for simulation and parameter estimation in pharmacokinetic systems. Comput Prog Biomed 1979 9 : 115 134.
13. d'Argenio DZ. Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharm 1981 9 : 739 756.
14. Endrenyi L, Chan FY. Optimal design of experiments for the estimation of precise hyperbolic kinetic and binding parameters. J Theor Biol 1981 90 : 241 263.
15. Endrenyi L. Design of Experiments for Estimating Enzyme and Pharmacokinetic Parameters in Kinetic Data Analysis. Design and Analysis of Enzyme and Pharmacokinetic Experiments. Plenum Press, New York, 1981 121 167.
16. Mentré F, Mallet A, Baccar D. Optimal design in random-effects regression models. Biometrika 1997 84 : 429 442.
17. Retout S, Duffull S, Mentré F. Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs. Comput Methods Programs Biomed 2001 65 : 141 151.
18. Duffull SB, Mentré F, Aarons L. Optimal design of a population pharmacodynamic experiment for ivabradine. Pharm Res 2001 18 : 83 9.
19. Duffull SB, Retout S, Mentré F. The use of simulated annealing for finding optimal population designs. Comput Methods Programs Biomed 2002 69 : 25 35.
20. Ogungbenro K, Graham G, Gueorguieva I, Aarons L. The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments. Comput Methods Programs Biomed 2005 80 : 115 125.
21. Gueorguieva I, Aarons L, Ogungbenro K, Jorga KM, Rodgers T, Rowland M. Optimal design for multivariate response pharmacokinetic models. J Pharmacokinet Pharmacodyn 2006 33 : 97 124.
22. Hooker AC, Foracchia M, Dodds MG, Vicini P. An evaluation of population D-optimal designs via pharmacokinetic simulations. Ann Biomed Eng 2003 31 : 98 111.
23. Aarons L. Population pharmacokinetics: theory and practice. Br J Clin Pharmacol 1991 32 : 669 670.
24. Aarons L. Population pharmacokinetics. Int J Clin Pharmacol Ther Toxicol 1992 30 : 520 522.
25. Graham G, Aarons L. Optimal blood sampling time windows for parameter estimation in population pharmacokinetic experiments. Stat Med 2006 25 : 4004 4019.
26. Ogungbenro K, Aarons L. An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments. J Biopharm Stat 2008 19 : 174 189.
27. Aarons L, Balant LP, Mentré F, Morselli PL, Rowland M, Steimer JL et al. Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies. Eur J Clin Pharmacol 1996 49 : 251 254.
28. Ogungbenro K, Aarons L. How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach. Eur J Clin Pharmacol 2008 64 : 705 713.
29. Beal SL, Sheiner LB. NONMEM Users Guides, Parts I-VII. NONMEM Project Group. University of California, San Francisco, 1992.
30. Lunn DJ, Best N, Thomas A, Wakefield J, Spiegelhalter D. Bayesian analysis of population PK/PD models: general concepts and software. J Pharmacokinet Pharmacodyn 2002 29 : 271 307.
31. Spiegelhalter D, Thomas A, Best N, Lunn DJ. WinBUGS Version 1.4 User Manual. MRC Biostatistics Unit, Cambridge, UK, 2003.
32. Kowalski KG, Hutmacher MM. Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study. Stat Med 2001 20 : 75 91.
33. White DB, Walawander CA, Liu DY, Grasela TH. Evaluation of hypothesis testing for comparing two populations using NONMEM analysis. J Pharmacokinet Biopharm 1992 20 : 295 313.
34. Lee PI. Design and power of a population pharmacokinetic study. Pharm Res 2001 18 : 75 82.
35. Ogungbenro K, Aarons L, Graham G. Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments. J Biopharm Stat 2006 16 : 135 150.
36. Kang D, Schwartz JB, Verotta D. A sample size computation method for non-linear mixed effects models with applications to pharmacokinetic models. Stat Med 2004 23 : 2551 2566.
37. Kang D, Schwartz JB, Verotta D. Sample size computations for PK/PD population models. J Pharmacokinet Pharmacodyn 2005 32 : 685 701.
38. Chenel M, Bouzom F, Aarons L, Ogungbenro K. Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDes. J Pharmacokinet Pharmacodyn 2008 35 : 635 659.
39. Chenel M, Bouzom F, Cazade F, Ogungbenro K, Aarons L, Mentre F. Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results. J Pharmacokinet Pharmacodyn 2008 35 : 661 681.
40. Ogungbenro K, Gueorguieva I, Majid O, Graham G, Aarons L. Optimal design for multiresponse pharmacokinetic-pharmacodynamic models: dealing with unbalanced designs. J Pharmacokinet Pharmacodyn 2007 34 : 313 331.
41. Ogungbenro K, Graham G, Gueorguieva I, Aarons L. Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experiments. J Biopharm Stat 2008 18 : 342 358.
42. Bazzoli C, Retout S, Mentre F. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model. Stat Med 2009 28 : 1940 1956.
43. Hooker A, Vicini P. Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments. AAPS J 2005 7 : E759 85.
44. Chaloner K. Optimal Bayesian experimental design for linear models. Ann Stat 1984 12 : 283 300.
45. Atkinson AC, Donev AN. Optimum Experimental Designs. Oxford University Press, Oxford, 1992.
46. Merle Y, Mentré F. Bayesian design criteria: computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model. J Pharmacokinet Biopharm 1995 23 : 101 125.
47. Tod M, Mentré F, Merle Y, Mallet A. Robust optimal design for the estimation of hyperparameters in population pharmacokinetics. J Pharmacokinet Biopharm 1998 26 : 689 716.
48. Wahlby U, Matolcsi K, Karlsson MO, Jonsson EN. Evaluation of type I error rates when modeling ordered categorical data in NONMEM. J Pharmacokinet Pharmacodyn 2004 31 : 61 74.
49. Lunn DJ, Wakefield J, Racine-Poon A. Cumulative logit models for ordinal data: a case study involving allergic rhinitis severity scores. Stat Med 2001 20 : 2261 2285.
50. McCullagh P, Nelder JA. Generalized Linear Models. Chapman and Hall, London, 1989.